ADT and the Risk of Major Adverse Cardiovascular Events

home / insights / adt-major-cardiovascular-risk
Cardio-Oncology and Prostate Cancer

EP. 1: Cardio-Oncology and Prostate Cancer

March 25th 2019
The Cardioprotective Role of Androgens

EP. 2: The Cardioprotective Role of Androgens

March 25th 2019
Adverse Effects of Hormone Therapy in Prostate Cancer

EP. 3: Adverse Effects of Hormone Therapy in Prostate Cancer

March 25th 2019
Data Supporting the Risk of MACEs in ADT

EP. 4: Data Supporting the Risk of MACEs in ADT

March 25th 2019
Effects of ADT on Morbidity and Mortality

EP. 5: Effects of ADT on Morbidity and Mortality

March 25th 2019
GnRH Antagonists Versus GnRH Agonists

EP. 6: GnRH Antagonists Versus GnRH Agonists

March 25th 2019
Real-World Patients With High Risk of MACEs

EP. 7: Real-World Patients With High Risk of MACEs

March 25th 2019
Standard of Care in Metastatic Prostate Cancer

EP. 8: Standard of Care in Metastatic Prostate Cancer

March 25th 2019
Optimizing Prevention of MACEs in Prostate Cancer

EP. 9: Optimizing Prevention of MACEs in Prostate Cancer

March 25th 2019
ADT and the Need for a Multidisciplinary Approach

EP. 10: ADT and the Need for a Multidisciplinary Approach

March 25th 2019